FOR THE NEXT GENERATION OF PHYSICIANS
← All USMLE guides
IMMUNOLOGY

Transplant rejection, GVHD and immunosuppressants.

Hyperacute, acute, chronic rejection and graft-versus-host disease with the drugs used to prevent them.

Rejection types are separated by timing and mechanism. Immunosuppressants are paired with their toxicities.

Rejection

  • Hyperacute: minutes to hours; preformed antibodies; type II; the graft must be removed.
  • Acute cellular: weeks to months; CD8 T cells; reversible with steroids.
  • Chronic: months to years; vascular fibrosis and obliterative changes.
  • Graft-versus-host disease: donor T cells attack recipient tissue after bone marrow transplant; rash, diarrhea and jaundice.

Drugs

Calcineurin inhibitors (cyclosporine, tacrolimus) block IL-2: nephrotoxicity, hypertension and tremor. Mycophenolate inhibits purine synthesis; azathioprine is metabolized to 6-mercaptopurine and interacts with allopurinol. Sirolimus blocks mTOR; basiliximab blocks IL-2 receptor; glucocorticoids induce apoptosis.

Matching

ABO and HLA matching, particularly HLA-DR, reduce rejection. Cross-matching detects antibodies to donor cells before transplantation.

Keep going in immunology

Related on USMLE WEB

Frequently asked questions

Which rejection occurs within minutes?

Hyperacute rejection.

What does tacrolimus inhibit?

Calcineurin, reducing IL-2 production.